Document is current
Any future updates will be listed below
-
Authors
Zhang, Wenchao
Miikeda, Aika
Zuckerman, Jonathan
Jia, Xun
Charugundla, Sarada
Zhou, Zhiqiang
Kaczor-Urbanowicz, Karolina Elżbieta
Magyar, Clara
Guo, Fangfei
Wang, Zeneng
Pellegrini, Matteo
Hazen, Stanley L.
Nicholas, Susanne B.
Lusis, Aldons J.
Shih, Diana M.
-
Funding
Funding for this research was provided by:
National Institutes of Health (1R01 HL144651-01)
National Institutes of Health (P01 HL147823)
National Institutes of Health (1R01 HL144651-01)
National Institutes of Health (1R01 HL144651-01)
National Institutes of Health (1R01 HL144651-01)
National Institutes of Health (P01 HL147823)
National Institutes of Health (P01 HL147823)
National Institutes of Health (1R01 HL144651-01)
National Institutes of Health (1R01 HL144651-01)
National Institutes of Health (1R01 HL144651-01)
National Institute of Mental Health (R01 HL103866)
National Institute of Mental Health (R01 HL103866)
National Institute of Mental Health (R01 HL103866)
- License Information
-
More Information
Article History
Received: 1 September 2020
Accepted: 8 December 2020
First Online: 12 January 2021
Competing interests
: SLH and ZW report being named as co-inventors on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics. SLH also reports being a paid consultant for Procter & Gamble, having received research funds from Procter & Gamble, and Roche Diagnostics, and both SLH and ZW report being eligible to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics or therapeutics from Cleveland Heart Lab (a subsidiary of Quest Diagnostics) and P&G. All other authors declare no competing interests.
